40-F Filing

AURINIA PHARMACEUTICALS INC. CIK: 1600620 FY 2018

Filing Information

Form Type	40-F
Accession Number	`0001628280-19-003130`
Period End Date	20181231
Filing Date	20190319
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	auph-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 55 Income Statement 34 Cash Flow Statement 54 Stockholders Equity 21

Balance Sheet 55 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalents`	$117.97M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$39.65M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$165.63M	USD	Point-in-time
Short term investments (note 5)	`CurrentInvestments`	-	USD	Point-in-time
Short term investments (note 5)	`CurrentInvestments`	$7.83M	USD	Point-in-time
Short term investments (note 5)	`CurrentInvestments`	$7.89M	USD	Point-in-time
Accounts receivable and accrued interest receivable	`CurrentTradeReceivables`	$217.00K	USD	Point-in-time
Accounts receivable and accrued interest receivable	`CurrentTradeReceivables`	$109.00K	USD	Point-in-time
Prepaid expenses, deposits and other	`CurrentPrepaymentsAndOtherCurrentAssets`	$1.68M	USD	Point-in-time
Prepaid expenses, deposits and other	`CurrentPrepaymentsAndOtherCurrentAssets`	$6.78M	USD	Point-in-time
Current assets	`CurrentAssets`	$175.25M	USD	Point-in-time
Current assets	`CurrentAssets`	$132.85M	USD	Point-in-time
Clinical trial contract deposits	`LongtermDeposits`	$448.00K	USD	Point-in-time
Clinical trial contract deposits	`LongtermDeposits`	$358.00K	USD	Point-in-time
Property and equipment (note 6)	`PropertyPlantAndEquipment`	$31.00K	USD	Point-in-time
Property and equipment (note 6)	`PropertyPlantAndEquipment`	$41.00K	USD	Point-in-time
Property and equipment (note 6)	`PropertyPlantAndEquipment`	$29.00K	USD	Point-in-time
Acquired intellectual property and other intangible assets (note 7)	`IntangibleAssetsOtherThanGoodwill`	$15.55M	USD	Point-in-time
Acquired intellectual property and other intangible assets (note 7)	`IntangibleAssetsOtherThanGoodwill`	$12.62M	USD	Point-in-time
Acquired intellectual property and other intangible assets (note 7)	`IntangibleAssetsOtherThanGoodwill`	$14.12M	USD	Point-in-time
Assets	`Assets`	$145.86M	USD	Point-in-time
Assets	`Assets`	$189.85M	USD	Point-in-time
Accounts payable and accrued liabilities (note 8)	`TradeAndOtherCurrentPayables`	$7.96M	USD	Point-in-time
Accounts payable and accrued liabilities (note 8)	`TradeAndOtherCurrentPayables`	$7.07M	USD	Point-in-time
Current portion of deferred revenue (note 9)	`DeferredIncomeClassifiedAsCurrent`	$118.00K	USD	Point-in-time
Current portion of deferred revenue (note 9)	`DeferredIncomeClassifiedAsCurrent`	$118.00K	USD	Point-in-time
Contingent consideration (note 10)	`Currentcontingentconsideration`	$73.00K	USD	Point-in-time
Contingent consideration (note 10)	`Currentcontingentconsideration`	$72.00K	USD	Point-in-time
Current liabilities	`CurrentLiabilities`	$8.15M	USD	Point-in-time
Current liabilities	`CurrentLiabilities`	$7.26M	USD	Point-in-time
Deferred revenue (note 9)	`DeferredIncomeClassifiedAsNoncurrent`	$442.00K	USD	Point-in-time
Deferred revenue (note 9)	`DeferredIncomeClassifiedAsNoncurrent`	$324.00K	USD	Point-in-time
Contingent consideration (note 10)	`Noncurrentcontingentconsideration`	$3.96M	USD	Point-in-time
Contingent consideration (note 10)	`Noncurrentcontingentconsideration`	$3.72M	USD	Point-in-time
Derivative warrant liabilities (notes 11 and 23)	`NoncurrentDerivativeFinancialLiabilities`	$11.79M	USD	Point-in-time
Derivative warrant liabilities (notes 11 and 23)	`NoncurrentDerivativeFinancialLiabilities`	$21.75M	USD	Point-in-time
Liabilities	`Liabilities`	$24.10M	USD	Point-in-time
Liabilities	`Liabilities`	$33.29M	USD	Point-in-time
Common shares (note 12)	`IssuedCapital`	$499.20M	USD	Point-in-time
Common shares (note 12)	`IssuedCapital`	$504.65M	USD	Point-in-time
Warrants (note 12)	`Warrants`	-	USD	Point-in-time
Warrants (note 12)	`Warrants`	$906.00K	USD	Point-in-time
Contributed surplus	`CapitalReserve`	$24.69M	USD	Point-in-time
Contributed surplus	`CapitalReserve`	$18.36M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncome`	$-805.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncome`	$-883.00K	USD	Point-in-time
Deficit	`RetainedEarnings`	$-415.96M	USD	Point-in-time
Deficit	`RetainedEarnings`	$-351.84M	USD	Point-in-time
Equity	`Equity`	$112.58M	USD	Point-in-time
Equity	`Equity`	$35.95M	USD	Point-in-time
Equity	`Equity`	$165.74M	USD	Point-in-time
Equity and liabilities	`EquityAndLiabilities`	$189.85M	USD	Point-in-time
Equity and liabilities	`EquityAndLiabilities`	$145.86M	USD	Point-in-time
Commitments and contingencies (note 20)	`CommitmentsAndContingencies1`	-	USD	Point-in-time
Commitments and contingencies (note 20)	`CommitmentsAndContingencies1`	-	USD	Point-in-time

Income Statement 34 line items

Line Item	Tag	Value	Unit	Period
Licensing revenue	`LicenceFeeIncome`	$418.00K	USD	Annual
Licensing revenue	`LicenceFeeIncome`	$118.00K	USD	Annual
Contract revenue	`Researchanddevelopmentrevenue`	$345.00K	USD	Annual
Contract revenue	`Researchanddevelopmentrevenue`	-	USD	Annual
Revenue	`Revenue`	$463.00K	USD	Annual
Revenue	`Revenue`	$418.00K	USD	Annual
Research and development (note 13)	`ResearchAndDevelopmentExpense`	$41.38M	USD	Annual
Research and development (note 13)	`ResearchAndDevelopmentExpense`	$33.93M	USD	Annual
Corporate, administration and business development (note 13)	`GeneralAndAdministrativeExpense`	$13.67M	USD	Annual
Corporate, administration and business development (note 13)	`GeneralAndAdministrativeExpense`	$12.10M	USD	Annual
Amortization of acquired intellectual property and other intangible assets (note 7)	`AmortisationIntangibleAssetsOtherThanGoodwill`	$1.43M	USD	Annual
Amortization of acquired intellectual property and other intangible assets (note 7)	`AmortisationIntangibleAssetsOtherThanGoodwill`	$1.54M	USD	Annual
Amortization of property and equipment	`DepreciationPropertyPlantAndEquipment`	$20.00K	USD	Annual
Amortization of property and equipment	`DepreciationPropertyPlantAndEquipment`	$22.00K	USD	Annual
Other expense (income) (note 14)	`OtherOperatingIncomeExpense`	$2.06M	USD	Annual
Other expense (income) (note 14)	`OtherOperatingIncomeExpense`	$196.00K	USD	Annual
Expenses	`OperatingExpense`	$47.29M	USD	Annual
Expenses	`OperatingExpense`	$54.56M	USD	Annual
Net loss before change in estimated fair value of derivative warrant liabilities	`ProfitLossFromOperatingActivities`	$-54.09M	USD	Annual
Net loss before change in estimated fair value of derivative warrant liabilities	`ProfitLossFromOperatingActivities`	$-46.87M	USD	Annual
Change in estimated fair value of derivative warrant liabilities (note 11)	`GainsLossesOnChangeInFairValueOfDerivatives`	$-23.92M	USD	Annual
Change in estimated fair value of derivative warrant liabilities (note 11)	`GainsLossesOnChangeInFairValueOfDerivatives`	$-9.95M	USD	Annual
Loss before income taxes	`ProfitLossBeforeTax`	$-70.79M	USD	Annual
Loss before income taxes	`ProfitLossBeforeTax`	$-64.05M	USD	Annual
Income tax expense (note 15)	`Taxexpenseincome`	-	USD	Annual
Income tax expense (note 15)	`Taxexpenseincome`	$73.00K	USD	Annual
Net loss for the year	`ProfitLoss`	$-64.12M	USD	Annual
Net loss for the year	`ProfitLoss`	$-70.79M	USD	Annual
Net change in fair value of short term investments (note 3)	`OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets`	-	USD	Annual
Net change in fair value of short term investments (note 3)	`OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets`	$-78.00K	USD	Annual
Net comprehensive loss for the year	`ComprehensiveIncome`	$-64.12M	USD	Annual
Net comprehensive loss for the year	`ComprehensiveIncome`	$-70.87M	USD	Annual
Basic and diluted loss per common share (in dollars per share)	`BasicAndDilutedEarningsLossPerShare`	$-0.92	USD	Annual
Basic and diluted loss per common share (in dollars per share)	`BasicAndDilutedEarningsLossPerShare`	$-0.76	USD	Annual

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss for the year	`ProfitLoss`	$-64.12M	USD	Annual
Net loss for the year	`ProfitLoss`	$-70.79M	USD	Annual
Amortization of deferred revenue	`AdjustmentsForIncreaseDecreaseInDeferredIncome`	$-118.00K	USD	Annual
Amortization of deferred revenue	`AdjustmentsForIncreaseDecreaseInDeferredIncome`	$-118.00K	USD	Annual
Amortization of property and equipment	`AdjustmentsForDepreciationExpense`	$20.00K	USD	Annual
Amortization of property and equipment	`AdjustmentsForDepreciationExpense`	$22.00K	USD	Annual
Amortization of acquired intellectual property and other intangible assets	`Amortizationofacquiredintellectualpropertyandotherintangibleassets`	$1.54M	USD	Annual
Amortization of acquired intellectual property and other intangible assets	`Amortizationofacquiredintellectualpropertyandotherintangibleassets`	$1.43M	USD	Annual
Change in value and amortization of short term investments discount (premium) (note 18)	`AdjustmentsForFairValueGainsLosses`	$13.00K	USD	Annual
Change in value and amortization of short term investments discount (premium) (note 18)	`AdjustmentsForFairValueGainsLosses`	$67.00K	USD	Annual
Revaluation of contingent consideration	`Revaluationofcontingentconsiderations`	$502.00K	USD	Annual
Revaluation of contingent consideration	`Revaluationofcontingentconsiderations`	$236.00K	USD	Annual
Loss on disposal of equipment	`GainsOnDisposalsOfPropertyPlantAndEquipment`	$-1.00K	USD	Annual
Loss on disposal of equipment	`GainsOnDisposalsOfPropertyPlantAndEquipment`	-	USD	Annual
Change in estimated fair value of derivative warrant liabilities	`AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives`	$-9.95M	USD	Annual
Change in estimated fair value of derivative warrant liabilities	`AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives`	$-23.92M	USD	Annual
Stock-based compensation	`AdjustmentsForSharebasedPayments`	$6.86M	USD	Annual
Stock-based compensation	`AdjustmentsForSharebasedPayments`	$4.24M	USD	Annual
Adjustments to reconcile profit (loss)	`AdjustmentsForReconcileProfitLoss`	$-40.72M	USD	Annual
Adjustments to reconcile profit (loss)	`AdjustmentsForReconcileProfitLoss`	$-45.61M	USD	Annual
Contingent consideration milestones paid	`Paymentofcontingentconsiderationmilestoneachievement`	-	USD	Annual
Contingent consideration milestones paid	`Paymentofcontingentconsiderationmilestoneachievement`	$2.15M	USD	Annual
Net change in other operating assets and liabilities (note 18)	`IncreaseDecreaseInWorkingCapital`	$6.00M	USD	Annual
Net change in other operating assets and liabilities (note 18)	`IncreaseDecreaseInWorkingCapital`	$-1.70M	USD	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	$-41.17M	USD	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	$-51.61M	USD	Annual
Purchase of short term investments	`PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities`	$98.00M	USD	Annual
Purchase of short term investments	`PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities`	$36.08M	USD	Annual
Proceeds on disposal/maturity of short term investments	`ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities`	$90.02M	USD	Annual
Proceeds on disposal/maturity of short term investments	`ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities`	$36.09M	USD	Annual
Purchase of equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$30.00K	USD	Annual
Purchase of equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$25.00K	USD	Annual
Capitalized patent costs	`PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities`	-	USD	Annual
Capitalized patent costs	`PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities`	$45.00K	USD	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-8.00M	USD	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-66.00K	USD	Annual
Net proceeds from issuance of common shares	`ProceedsFromIssueOfOrdinaryShares`	$162.32M	USD	Annual
Net proceeds from issuance of common shares	`ProceedsFromIssueOfOrdinaryShares`	-	USD	Annual
Proceeds from exercise of derivative warrants	`Proceedsfromexerciseofderivativewarrants`	$8.68M	USD	Annual
Proceeds from exercise of derivative warrants	`Proceedsfromexerciseofderivativewarrants`	-	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromIssuingOtherEquityInstruments`	$3.07M	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromIssuingOtherEquityInstruments`	$232.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromExerciseOfOptions`	$943.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromExerciseOfOptions`	$3.91M	USD	Annual
Net cash generated from financing activities	`CashFlowsFromUsedInFinancingActivities`	$4.01M	USD	Annual
Net cash generated from financing activities	`CashFlowsFromUsedInFinancingActivities`	$175.15M	USD	Annual
(Decrease) Increase in cash and cash equivalents during the year	`IncreaseDecreaseInCashAndCashEquivalents`	$125.98M	USD	Annual
(Decrease) Increase in cash and cash equivalents during the year	`IncreaseDecreaseInCashAndCashEquivalents`	$-47.66M	USD	Annual
Cash and cash equivalents Beginning of year	`CashAndCashEquivalents`	$117.97M	USD	Point-in-time
Cash and cash equivalents Beginning of year	`CashAndCashEquivalents`	$39.65M	USD	Point-in-time
Cash and cash equivalents Beginning of year	`CashAndCashEquivalents`	$165.63M	USD	Point-in-time
Cash and cash equivalents End of year	`CashAndCashEquivalents`	$117.97M	USD	Point-in-time
Cash and cash equivalents End of year	`CashAndCashEquivalents`	$39.65M	USD	Point-in-time
Cash and cash equivalents End of year	`CashAndCashEquivalents`	$165.63M	USD	Point-in-time

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Profit (loss) before tax	`ProfitLossBeforeTax`	$-70.79M	USD	Annual
Profit (loss) before tax	`ProfitLossBeforeTax`	$-64.05M	USD	Annual
Equity, opening balance	`Equity`	$112.58M	USD	Point-in-time
Equity, opening balance	`Equity`	$35.95M	USD	Point-in-time
Equity, opening balance	`Equity`	$165.74M	USD	Point-in-time
Issue of common shares	`IssueOfEquity`	$173.10M	USD	Annual
Share issue costs	`ShareIssueRelatedCost`	$10.78M	USD	Annual
Exercise of warrants	`IncreaseDecreaseThroughExerciseOfWarrantsEquity`	$3.07M	USD	Annual
Exercise of warrants	`IncreaseDecreaseThroughExerciseOfWarrantsEquity`	$232.00K	USD	Annual
Exercise of derivative warrants	`Increasedecreasethroughexerciseofderivativeliabilitywarrantsequity`	$29.95M	USD	Annual
Exercise of stock options	`IncreaseDecreaseThroughExerciseOfOptions`	$3.91M	USD	Annual
Exercise of stock options	`IncreaseDecreaseThroughExerciseOfOptions`	$943.00K	USD	Annual
Stock-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$4.24M	USD	Annual
Stock-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$6.86M	USD	Annual
Net loss for the year	`ProfitLoss`	$-64.12M	USD	Annual
Net loss for the year	`ProfitLoss`	$-70.79M	USD	Annual
Net loss and comprehensive loss for the year	`ComprehensiveIncome`	$-64.12M	USD	Annual
Net loss and comprehensive loss for the year	`ComprehensiveIncome`	$-70.87M	USD	Annual
Equity, closing balance	`Equity`	$112.58M	USD	Point-in-time
Equity, closing balance	`Equity`	$35.95M	USD	Point-in-time
Equity, closing balance	`Equity`	$165.74M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.